Kidney care advocates press Congress to act on trio of bills
Legislation aimed at improving care for people with rare kidney conditions
Written by |
Legislation in Congress is aimed at improving kidney care. (Photo by iStock)
Representatives from the American Kidney Fund (AKF) and the IgA Nephropathy Foundation joined dozens of patient advocates on Capitol Hill last week to urge lawmakers to pass a trio of bills to improve access to care for people with rare kidney diseases, such as IgA nephropathy.
“By joining forces with the American Kidney Fund for Hill Day, we are amplifying the voices of people affected by IgA nephropathy and bringing their experiences directly to policymakers,” Bonnie Schneider, director and co-founder of the IgA Nephropathy Foundation, said in a press release from the two organizations. “Together, we can raise awareness of the challenges this community faces and advocate for policies that promote earlier diagnosis, greater access to care, and continued innovation in treatment. We are proud to stand alongside patients, care partners, and advocates to help create a better future for everyone affected by IgAN.”
IgAN is characterized by the buildup of IgA antibodies in the kidneys’ filtering units, causing inflammation and damage that can ultimately lead to kidney failure.
The advocates are pushing for passage of the New Era of Preventing End-Stage Kidney Disease Act (H.R. 1518), the Access to Genetic Counselor Services Act (HR 6280/S. 3607), and the Living Donor Protection Act (HR 4582/4583/S. 1552).
Centers of excellence, genetic counseling, donor protection
HR 1518 would establish centers of excellence at the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institutes of Health branch that studies kidney disease. These centers would be tasked with studying rare kidney diseases and increasing awareness and care for these conditions, especially in rural and underserved areas.
The legislation would also require the Secretary of Health and Human Services to conduct studies to evaluate diagnostic and therapeutic methods for rare kidney diseases and approaches to slow progression to end-stage kidney disease, or kidney failure. The bill also allocates funds to improve kidney-related training for healthcare providers.
“People living with a rare kidney disease often have a more difficult time receiving an accurate diagnosis, which can mean they do not receive the best course of treatment right away,” said LaVarne A. Burton, president and CEO of the AKF. “Early detection and prevention are the best ways to stop or slow the progression of kidney disease to kidney failure, and misdiagnosis or lack of access to healthcare services can make a critical difference in preserving kidney function.” The legislation, Burton said, would “help address these needs.”
The Access to Genetic Counselor Services Act of 2025 (HR 6280/S. 3607) would expand access to genetic counselors, healthcare professionals who are experts in interpreting the genetic testing that is essential for diagnosing thousands of diseases, including many that affect the kidneys.
The bill would expand access to these clinicians by allowing them to bill Medicare, the government-run program that provides health insurance to Americans aged 65 or older or with disabilities.
The Living Donor Protection Act (HR 4582/4583/S. 1552) would prohibit insurers from declining or limiting coverage for people who have donated a kidney or another organ. The law would apply to any life insurance, disability insurance, or long-term care insurance policy.